Manufacturers Life Insurance Company, The Travere Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 47,045 shares of TVTX stock, worth $955,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,045
Previous 29,114
61.59%
Holding current value
$955,483
Previous $239,000
175.31%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding TVTX
# of Institutions
196Shares Held
84.9MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$155 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$140 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$95.1 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$88.2 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.3B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...